Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Millions of people are to be given access to digital treatment for insomnia as an alternative to sleeping pills. Study by Colin Espie et al shows that Sleepio improves wellbeing in nearly three quarters of participants.

Apply by 10 March for 2017/18 for a PGDip or MSc. The course is also available as CPD modules. It is hosted by the Sleep and Circadian Neuroscience Institute (SCNi) in our Department. © Shutterstock

The Sleepio app – a cognitive behavioural therapy based programme which can be accessed via smartphone or web - is to be made available initially in Berkshire, Buckinghamshire and Oxfordshire later this month before being rolled out across other areas in the South East in early 2019. It is the first NHS rollout of direct-access digital medicine - fully automated, self-help programmes, easily accessible via app or web.

We are delighted to see this important research be so rapidly translated to the NHS for clinical benefit. The recognition that sleep is of fundamental importance for our well-being and clinical health is growing and studies such as these that help us understand and tackle current issues we face as a society regarding sleep deficit are vital.

- Professor Irene Tracey, Head of the Nuffield Department of Clinical Neurosciences

Sleepio works by helping people to resolve their persistent sleep problems by discovering their ideal personal sleep pattern, and by overcoming the 'racing mind' that so often prevents people from sleeping. The announcement comes as the largest research trial into the impact of digital cognitive behavioural therapy (dCBT) on adults with insomnia demonstrated the link between better sleep and improved overall health. Published in the latest JAMA Psychiatry, the Oxford University led 12-month UK study showed that dCBT based intervention Sleepio improved overall wellbeing, mental health and quality of life.

The South East NHS roll-out of the Sleepio programme is designed to find the best ways of helping people to access digital medicine through partnering with stakeholders such as GPs, pharmacies, libraries and local employers. It will develop a blueprint for wider uptake of digital medicine across the NHS in England in a bid to improve sleep health whilst reducing the current over-reliance on medication, which is used to treat the estimated 20% of working adults that suffer from chronic sleeplessness.

Clinical guidelines recommend the psychological approach known as cognitive behavioural therapy (CBT) for insomnia. However, treatment is currently dominated by medication, which can have unpleasant or harmful side effects. Last year, over 12 million prescriptions for insomnia were written, at a cost to the NHS of £72m - 1 prescription for every GP, every day of the year*. On the other hand Sleepio which is digital CBT has been shown in clinical trials to help over three quarters of insomnia sufferers achieve normal sleep.

'Sleep ranks with air, water and food as one of the essentials of life, yet 10% to 12% of the population don’t get enough of it due to insomnia,' said study lead author Colin Espie, Oxford University Professor of Sleep Medicine and Chief Medical Officer of Big Health. 'Furthermore, most people who seek help with insomnia do so because of its negative impact on their daytime quality of life. Our study suggests that this new form of digital medicine could be a powerful way to help millions of people not just sleep better, but achieve better mental and physical well-being as a result.' This research was supported by the National Institute for Health Research Oxford Biomedical Research Centre.

Sleepio is one of the first digital health applications ever to be reviewed by NICE, and has been supported by the NHS Innovation Accelerator since 2015. Sleepio has now been tested in eight clinical trials, including the largest ever trial of a psychological intervention, significantly improving both sleep and mental health outcomes (Freeman et al. 2017).

Similar stories

New insights gained into how the brain encodes information about the world

Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Royal Academy of Engineering Research Fellowship

Dr Rezvan Farahibozorg has received one of 17 Royal Academy of Engineering Research Fellowships for 2022.

Three New Professors

Many congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.